EMEA-002807-PIP01-20
Key facts
| Active substance |
Durlobactam / sulbactam (SUL-DUR)
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0499/2020
|
| PIP number |
EMEA-002807-PIP01-20
|
| Pharmaceutical form(s) |
Powder for solution for injection
|
| Condition(s) / indication(s) |
Treatment of infections due to organisms of the Acinetobacter baumannii-calcoaceticus complex
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Entasis Therapeutics Inc.
Email: Enquiries@entasistx.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|